| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | 0.03 | 0.9 |
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | 0.0085 | 0.9 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.0037 | 0.9 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.005 | 0.9 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | -0.0051 | 0.9 |
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | -0.0074 | 0.9 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.0034 | 0.9 |
| mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | -0.0076 | 0.9 |
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | 0.0059 | 0.9 |
| mRNA | Imatinib | FIMM | pan-cancer | AAC | -0.016 | 0.9 |